AC Immune SA (ACIU)
2.67
+0.13
(+5.12%)
USD |
NASDAQ |
Dec 10, 13:47
AC Immune Total Liabilities (Quarterly): 137.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 3.474B |
| CRISPR Therapeutics AG | 329.33M |
| Addex Therapeutics Ltd. | 1.725M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 20.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.68M |
| Shareholders Equity (Quarterly) | 78.48M |
| Debt to Equity Ratio | 0.0746 |
| Current Ratio | 1.157 |
| Net Debt Paydown Yield | -0.16% |